Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU
source: pixabay.com

Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU

According to a story from mrknewsroom.com, the pharmaceutical companies Merck and AstraZeneca recently announced that the marketing application for the investigational drug olaparib (brand name Lynparza) was recently certified for…

Continue Reading Treatment for BRCA-Mutated Breast Cancer Makes Another Regulatory Hurdle in the EU

Here’s What You Should Know Before Taking 23andMe’s BRCA-Mutated Breast Cancer Test

According to a story from sunmag.net, 23andMe, the genetics testing company widely known for its ancestral analysis measures, is now offering a genetics test to measure your risk of BRCA1…

Continue Reading Here’s What You Should Know Before Taking 23andMe’s BRCA-Mutated Breast Cancer Test
Author Emma Hannigan Reveals The Beginning of the End of Her Fight With Breast Cancer
pixel2013 / Pixabay

Author Emma Hannigan Reveals The Beginning of the End of Her Fight With Breast Cancer

According to a story from independent.ie, acclaimed author Emma Hannigan announced that her final options for treatment had been exhausted in her fight with BRCA-mutated breast cancer. Her doctors have…

Continue Reading Author Emma Hannigan Reveals The Beginning of the End of Her Fight With Breast Cancer
Would YOU Make a Preemptive Strike Against a BRCA-Mutation or Lynch Syndrome?
SilviaP_Design / Pixabay

Would YOU Make a Preemptive Strike Against a BRCA-Mutation or Lynch Syndrome?

What happens when you’re not the cancer that everyone is talking about? Funding, research, and headlines can often be noticeably lacking when you’re just a run-of-the-mill, life-threatening gene mutation, according…

Continue Reading Would YOU Make a Preemptive Strike Against a BRCA-Mutation or Lynch Syndrome?